Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03457896
Title Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors NSABP Foundation Inc

colorectal cancer


Cetuximab + Neratinib

Neratinib + Trastuzumab

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST